Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
4-Epidoxycycline: an alternative to doxycycline to control gene expression in conditional mouse models.
Eger K, Hermes M, Uhlemann K, Rodewald S, Ortwein J, Brulport M, Bauer AW, Schormann W, Lupatsch F, Schiffer IB, Heimerdinger CK, Gebhard S, Spangenberg C, Prawitt D, Trost T, Zabel B, Sauer C, Tanner B, Kolbl H, Krugel U, Franke H, Illes P, Madaj-Sterba P, Bockamp EO, Beckers T, Hengstler JG. Eger K, et al. Among authors: schiffer ib. Biochem Biophys Res Commun. 2004 Oct 22;323(3):979-86. doi: 10.1016/j.bbrc.2004.08.187. Biochem Biophys Res Commun. 2004. PMID: 15381096
Oncogene-blocking therapies: new insights from conditional mouse tumor models.
Hengstler JG, Bockamp EO, Hermes M, Brulport M, Bauer A, Schormann W, Schiffer IB, Hausherr C, Eshkind L, Antunes C, Franzen A, Krishnamurthi K, Lausch E, Lessig R, Chakrabarti T, Prawitt D, Zabel B, Spangenberg C. Hengstler JG, et al. Among authors: schiffer ib. Curr Cancer Drug Targets. 2006 Nov;6(7):603-12. doi: 10.2174/156800906778742488. Curr Cancer Drug Targets. 2006. PMID: 17100566 Review.
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour model.
Hermes M, Schormann W, Brulport M, Uhlemann K, Lupatsch F, Horn LC, Schumann A, Allgaier C, Weishaupt M, Engeland K, Müller GA, Mössner J, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Lausch E, Prawitt D, Wilhelm C, Hengstler JG. Hermes M, et al. Among authors: schiffer ib. Br J Cancer. 2008 May 6;98(9):1525-32. doi: 10.1038/sj.bjc.6604318. Epub 2008 Apr 29. Br J Cancer. 2008. PMID: 18454161 Free PMC article.
ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
Spangenberg C, Lausch EU, Trost TM, Prawitt D, May A, Keppler R, Fees SA, Reutzel D, Bell C, Schmitt S, Schiffer IB, Weber A, Brenner W, Hermes M, Sahin U, Türeci O, Koelbl H, Hengstler JG, Zabel BU. Spangenberg C, et al. Among authors: schiffer ib. Cancer Res. 2006 Apr 1;66(7):3715-25. doi: 10.1158/0008-5472.CAN-05-2823. Cancer Res. 2006. PMID: 16585198
ErbB-3 predicts survival in ovarian cancer.
Tanner B, Hasenclever D, Stern K, Schormann W, Bezler M, Hermes M, Brulport M, Bauer A, Schiffer IB, Gebhard S, Schmidt M, Steiner E, Sehouli J, Edelmann J, Läuter J, Lessig R, Krishnamurthi K, Ullrich A, Hengstler JG. Tanner B, et al. Among authors: schiffer ib. J Clin Oncol. 2006 Sep 10;24(26):4317-23. doi: 10.1200/JCO.2005.04.8397. Epub 2006 Aug 8. J Clin Oncol. 2006. PMID: 16896008
Role of the progesterone receptor for paclitaxel resistance in primary breast cancer.
Schmidt M, Bremer E, Hasenclever D, Victor A, Gehrmann M, Steiner E, Schiffer IB, Gebhardt S, Lehr HA, Mahlke M, Hermes M, Mustea A, Tanner B, Koelbl H, Pilch H, Hengstler JG. Schmidt M, et al. Among authors: schiffer ib. Br J Cancer. 2007 Jan 29;96(2):241-7. doi: 10.1038/sj.bjc.6603538. Epub 2007 Jan 9. Br J Cancer. 2007. PMID: 17211474 Free PMC article.
16 results